Biogen
Drug Manufacturing & Research
Company Overview
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; ADUHELM to treat Alzheimer's disease; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE; and BYOOVIZ, a ranibizumab biosimilar referencing LUCENTIS. It offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; OCREVUS for relapsing MS and primary progressive MS; LUNSUMIO to treat relapsed or ref
Top C-suite Members of Company
Connect with key decision-makers at Biogen. View contact details of C-suite executives and leadership team.
| Name | Title | Contact | |
|---|---|---|---|
| Christopher Viehbac | President and Chief Executive Officer | c****.@biogen.com | |
| Robin Kramer | Chief Financial Officer | r****r@biogen.com | |
| Guy Hadari | Senior VP | g****i@biogen.com | |
| Ginger Gregory | Chief Human Resources Officer | g****y@biogen.com | |
| Alisha Alaimo | President and Head | a****o@biogen.com | |
| Susan Alexander | Chief Legal Officer | s****r@biogen.com | |
| Hannah Moore | Lead | h****e@biogen.com | |
| Daniel Quirk | Chief Medical Officer | d****k@biogen.com | |
| Sean Godbout | Vice President | s****t@biogen.com | |
| Denna Williams | Chief Procurement Officer | d****s@biogen.com | |
| Vinicius Carvalho | Controller | v****o@biogen.com | |
| Susie Chen | Internal Greater Controller | s****n@biogen.com | |
| Mileidy Alvarado Su | Finance Controller | m****.@biogen.com | |
| Ana Laura | Controller | a****a@biogen.com | |
| Talha Fancy | Gulf Cluster | t****y@biogen.com | |
| Chen Chen | Internal | c****n@biogen.com | |
| Guy Hadari | Senior VP | g****i@biogen.com | |
| Alisha Alaimo | President and Head | a****o@biogen.com | |
| Christopher Viehbac | President and Chief Executive Officer | c****.@biogen.com | |
| Robin Kramer | Chief Financial Officer | r****r@biogen.com | |
| Daniel Quirk | Chief Medical Officer | d****k@biogen.com | |
| Susan Alexander | Chief Legal Officer | s****r@biogen.com |
Email Formats
Discover the email patterns used at Biogen to connect with the right people.
The predominant email format at Biogen is first.last (e.g., jon.doe@biogen.com), utilized by 28.51% of all professional email addresses at the organization.
| Email Format | Example | Percentage |
|---|---|---|
| first.last | jon.doe@biogen.com | 28.51% |
| first.last | jon.doe@biogenidec.com | 23.43% |
| first + last | jondoe@biogen.com | 20.64% |
| first_last | jon_doe@biogen.com | 18.52% |
| first | jon@biogen.com | 9.02% |
Email Verification Tool
Get verified email addresses of any IBM employee. Enjoy 100 free lookups every month.
